# BEESWAX (beeswax) — Global Cosmetic Regulatory & Formulation Monograph

- **Canonical URL**: https://www.inciname.com/en/ingredients/beeswax
- **Standard INCI**: `BEESWAX`
- **KR MFDS Standard Name**: `비즈왁스`
- **CAS No.**: `8006-40-4`
- **EC / EINECS No.**: `232-383-7`
- **Origin**: `animal`
- **Functions**: 향료, 피부컨디셔닝제, 점도조절제, 결합제, 유화안정제
- **Molecular Formula / MW**: `—` (— g/mol)

## 1. 7-Track Official Regulatory Label Names
| Track | Official Label Nomenclature |
| :--- | :--- |
| KR (MFDS Standard) | 비즈왁스 |
| KR (Former Names) | — |
| EU (CosIng 1223/2009) | CERA ALBA |
| US (PCPC / MoCRA INCI) | BEESWAX |
| US (FDA OTC Monograph) | — |
| CN (NMPA IECIC) | 蜂蜡 |
| JP (JCIA / MHLW QD) | ミツロウ (QD: サラシミツロウ) |

## 2. Layer 1 — Global 6-Region Statutory Summary
- **KR (MFDS)**: `none`
- **EU (1223/2009)**: `none`
- **US (FDA/MoCRA)**: `none`
- **CN (NMPA IECIC)**: `allowed` (Entry: `2338`)
- **JP (MHLW)**: `none`
- **ASEAN (ACD)**: `none`



## 3. Layer 2 — Toxicological & Historical Safe Use Concentrations
- Listed within general cosmetic GMP safety thresholds.

## 4. Layer 3 — Formulation Quartiles & Compatibility
- **Optimal pH Window**: 4 – 8
- **Max Process Temp**: ≤ 50°C
- **Synergy Pairings**: GLYCERIN, CAPRYLIC/CAPRIC TRIGLYCERIDE, TOCOPHEROL
- **Incompatibilities**: Verify phase compatibility under extreme pH or high electrolyte loads

## 5. Academic Monograph
■ [1. Chemical Identity & International Labeling Nomenclature]
  - INCI Name: BEESWAX | CAS No.: 8006-40-4 | EC No.: 232-383-7
  - Origin: ANIMAL | Functions: , , , , 
  - Physicochemical Profile: Formula      | MW /(Polymer/Complex) | /   | Ionic Nature: non-ionic | CosIng/MFDS 
  - Official Regional Label Names: US [BEESWAX] · EU [CERA ALBA] · CN [蜂蜡] · JP [ミツロウ] · JP Quasi-Drug [サラシミツロウ]
■ [2. Dermatological Mechanism of Action & Functional Role]
  - Beeswax is the purified wax from the honeycomb of the bee, Apis mellifera , free from all other waxes. Classified under origin 'animal', it acts within the cosmetic vehicle or stratum corneum to deliver , , , ,  performance and structural formulation stability.
■ [3. Global 6-Jurisdiction Regulatory Status & Safety Limits (Layer 1 & Layer 2)]
  - Regional Summary: KR: NONE | EU: NONE | US: NONE | CN: ALLOWED | JP: NONE | ASEAN: NONE (CN IECIC (2025) Entry No. 2338 (蜂蜡))
  - No specific Annex prohibition or numeric restriction across the 6 major jurisdictions (Permitted under general GMP safety assessment).
  - Official Safety & Historical Use Concentration (Layer 2): Quantum satis (QS) within standard cosmetic safety margins
■ [4. Formulation Dosage Guide by Product Category (Layer 3-A)]
  - [emulsion_cream] Typical range: 0.3 ~ 15.0% (Median 1.5%, Ref: Global Starter Formulation Library Statistical Distribution (n=9, GRANT 6 · SEPPIC 2 · ELEMENTIS 1)) — Emulsion cream & lotion structural / conditioning agent
  - [sun_color] Typical range: 0.5 ~ 10.0% (Median 2.5%, Ref: Global Starter Formulation Library Statistical Distribution (n=16, GRANT 14 · ELEMENTIS 2)) — Sun care & color cosmetics dispersion / sensory modifier
■ [5. Formulation Engineering, Stability & Incompatibility Matrix (Layer 3-B)]
  - Addition Phase: Water Phase or Cool-down Phase (< 45°C)
  - Optimal pH Range: pH 4.0 ~ 8.0 | Max Process Temp: Max 50°C | Electrolyte Tolerance: MEDIUM
  - Incompatibility / Caution: Verify phase compatibility under extreme pH or high electrolyte loads
  - Synergy Pairings: GLYCERIN, CAPRYLIC/CAPRIC TRIGLYCERIDE, TOCOPHEROL | Reference Trade Names: BEESWAX
■ [6. Peer-Reviewed Literature & Official Compendia Evidence]
  - PMID 36999457 (2023, J Cosmet Dermatol): A review of the use of beeswax in skincare.
  - PMID 42074130 (2026, Int J Mol Sci): Beeswax in Pharmaceutical Sciences: A Comprehensive Review of Its Chemical Composition, Functional Applications, Types, 
  - PMID 41892232 (2026, Biology (Basel)): Brood-Derived Fat Extracts from Apis mellifera as Sustainable Alternatives to Beeswax in Topical Nanostructured Lipid Ca

## 6. Linked PubMed Literature
- [PMID: 36999457] A review of the use of beeswax in skincare. — *J Cosmet Dermatol* (2023)
- [PMID: 42074130] Beeswax in Pharmaceutical Sciences: A Comprehensive Review of Its Chemical Composition, Functional Applications, Types, and Formulation Roles — *Int J Mol Sci* (2026)
- [PMID: 41892232] Brood-Derived Fat Extracts from Apis mellifera as Sustainable Alternatives to Beeswax in Topical Nanostructured Lipid Carriers — *Biology (Basel)* (2026)
- [PMID: 41663074] Propolis and Beeswax in Cosmetics: A Market Survey and Literature Review on Their Relationship and Role in Allergic Contact Dermatitis — *Contact Dermatitis* (2026)
- [PMID: 41579432] Evaluation of the efficacy of local application of bee products in the care of diaper dermatitis in infants: A randomized controlled trial — *J Pediatr Nurs* (2026)
- [PMID: 41470872] Knowledge and Use of Bee Products in Lithuania — *Nutrients* (2025)
- [PMID: 41365644] Anti-Aggregation System for the Enhanced Transdermal Delivery of Cell Membrane-Coated Nanoparticles — *ACS Nano* (2025)
- [PMID: 42278799] Interventions for the Prevention and Management of Nipple Trauma in Breastfeeding Women: A Systematic Review — *Healthcare (Basel)* (2026)
- [PMID: 42201878] Gelation in Oleogels: A Rheological Framework for Soft Material Formulation — *Langmuir* (2026)
- [PMID: 42130642] Qualitative phytochemical profiling, antioxidant activity, and development of a water-in-oil cream containing combined oil and water infusions of frankincense resin (Boswellia spp.): a preliminary in vitro study — *J Pharm Pharm Sci* (2026)
- [PMID: 41886392] Reproducing an Edo Period Orbital Epithesis with Wood and Crystal — *J Hist Dent* (2026)
- [PMID: 41465502] Ensuring the Safe Use of Bee Products: A Review of Allergic Risks and Management — *Int J Mol Sci* (2025)
- [PMID: 41457672] Bioinspired Heat-Induced Viscoelasticity-Switchable Electrodes for Conformal Brain-Computer Interfaces — *Adv Mater* (2026)